Aktuelle Neurologie, Table of Contents Aktuelle Neurologie 2014; 41(03): 181-182DOI: 10.1055/s-0034-1369927 Kompetenznetz Multiple Sklerose © Georg Thieme Verlag KG Stuttgart · New York Aktuelles aus der Forschung T. Menge 1 Zentrum Neurologie und Neuropsychiatrie, LVR-Klinikum, Heinrich-Heine-Universität, Düsseldorf , G. Meyer zu Hörste 2 Neurologische Klinik, Heinrich-Heine-Universität, Düsseldorf 3 Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA › Author Affiliations Recommend Article Abstract Buy Article Full Text References Literatur 1 Hauser SL, Waubant E, Arnold DL et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008; 358: 676-688 2 Kappos L, Li D, Calabresi PA et al. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet 2011; 378: 1779-1787 3 Sorensen PS, Lisby S, Grove R et al. Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study. Neurology 2014; 82: 573-581 4 Molnarfi N, Schulze-Topphoff U, Weber MS et al. MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med 2013; 210: 2921-2937 5 Srivastava R, Aslam M, Kalluri SR et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med 2012; 367: 115-123 6 Kraus V, Srivastava R, Kalluri SR et al. Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease. Neurology 2014; 82: 470-473 7 Sato DK, Callegaro D, Lana-Peixoto MA et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014; 82: 474-481 8 Titulaer MJ, Höftberger R, Iizuka T et al. Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis. Ann Neurol 2014; accepted for publication; 9 Korn T, Reddy J, Gao W et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007; 13: 423-431 10 Liu Y, Carlsson R, Comabella M et al. FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS. Nat Med 2014; in press; 11 Paolillo A, Buzzi MG, Giugni E et al. The effect of Bacille Calmette-Guerin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS. J Neurol 2003; 250: 247-248 12 Ristori G, Romano S, Cannoni S et al. Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS. Neurology 2014; 82: 41-48
